Safder S Ganaie, Madeline M Schwarz, Cynthia M McMillen, David A Price, Annie X Feng, Joseph R Albe, Wenjie Wang, Shane Miersch, Anthony Orvedahl, Aidan R Cole, Monica F Sentmanat, Nawneet Mishra, Devin A Boyles, Zachary T Koenig, Michael R Kujawa, Matthew A Demers, Ryan M Hoehl, Austin B Moyle, Nicole D Wagner, Sarah H Stubbs, Lia Cardarelli, Joan Teyra, Anita McElroy, Michael L Gross, Sean P J Whelan, John Doench, Xiaoxia Cui, Tom J Brett, Sachdev S Sidhu, Herbert W Virgin, Takeshi Egawa, Daisy W Leung, Gaya K Amarasinghe, Amy L Hartman
{"title":"Lrp1 is a host entry factor for Rift Valley fever virus.","authors":"Safder S Ganaie, Madeline M Schwarz, Cynthia M McMillen, David A Price, Annie X Feng, Joseph R Albe, Wenjie Wang, Shane Miersch, Anthony Orvedahl, Aidan R Cole, Monica F Sentmanat, Nawneet Mishra, Devin A Boyles, Zachary T Koenig, Michael R Kujawa, Matthew A Demers, Ryan M Hoehl, Austin B Moyle, Nicole D Wagner, Sarah H Stubbs, Lia Cardarelli, Joan Teyra, Anita McElroy, Michael L Gross, Sean P J Whelan, John Doench, Xiaoxia Cui, Tom J Brett, Sachdev S Sidhu, Herbert W Virgin, Takeshi Egawa, Daisy W Leung, Gaya K Amarasinghe, Amy L Hartman","doi":"10.1016/j.cell.2021.09.001","DOIUrl":null,"url":null,"abstract":"<p><p>Rift Valley fever virus (RVFV) is a zoonotic pathogen with pandemic potential. RVFV entry is mediated by the viral glycoprotein (Gn), but host entry factors remain poorly defined. Our genome-wide CRISPR screen identified low-density lipoprotein receptor-related protein 1 (mouse Lrp1/human LRP1), heat shock protein (Grp94), and receptor-associated protein (RAP) as critical host factors for RVFV infection. RVFV Gn directly binds to specific Lrp1 clusters and is glycosylation independent. Exogenous addition of murine RAP domain 3 (mRAP<sub>D3</sub>) and anti-Lrp1 antibodies neutralizes RVFV infection in taxonomically diverse cell lines. Mice treated with mRAP<sub>D3</sub> and infected with pathogenic RVFV are protected from disease and death. A mutant mRAPD3 that binds Lrp1 weakly failed to protect from RVFV infection. Together, these data support Lrp1 as a host entry factor for RVFV infection and define a new target to limit RVFV infections.</p>","PeriodicalId":45,"journal":{"name":"Journal of Chemical Theory and Computation","volume":" ","pages":"5163-5178.e24"},"PeriodicalIF":5.7000,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786218/pdf/nihms-1742896.pdf","citationCount":"38","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Chemical Theory and Computation","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.cell.2021.09.001","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/9/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}
引用次数: 38
Abstract
Rift Valley fever virus (RVFV) is a zoonotic pathogen with pandemic potential. RVFV entry is mediated by the viral glycoprotein (Gn), but host entry factors remain poorly defined. Our genome-wide CRISPR screen identified low-density lipoprotein receptor-related protein 1 (mouse Lrp1/human LRP1), heat shock protein (Grp94), and receptor-associated protein (RAP) as critical host factors for RVFV infection. RVFV Gn directly binds to specific Lrp1 clusters and is glycosylation independent. Exogenous addition of murine RAP domain 3 (mRAPD3) and anti-Lrp1 antibodies neutralizes RVFV infection in taxonomically diverse cell lines. Mice treated with mRAPD3 and infected with pathogenic RVFV are protected from disease and death. A mutant mRAPD3 that binds Lrp1 weakly failed to protect from RVFV infection. Together, these data support Lrp1 as a host entry factor for RVFV infection and define a new target to limit RVFV infections.
期刊介绍:
The Journal of Chemical Theory and Computation invites new and original contributions with the understanding that, if accepted, they will not be published elsewhere. Papers reporting new theories, methodology, and/or important applications in quantum electronic structure, molecular dynamics, and statistical mechanics are appropriate for submission to this Journal. Specific topics include advances in or applications of ab initio quantum mechanics, density functional theory, design and properties of new materials, surface science, Monte Carlo simulations, solvation models, QM/MM calculations, biomolecular structure prediction, and molecular dynamics in the broadest sense including gas-phase dynamics, ab initio dynamics, biomolecular dynamics, and protein folding. The Journal does not consider papers that are straightforward applications of known methods including DFT and molecular dynamics. The Journal favors submissions that include advances in theory or methodology with applications to compelling problems.